These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16305058)

  • 1. Whence and whither the fixed-dose combination?
    Bailey CJ
    Diab Vasc Dis Res; 2005 May; 2(2):51-3. PubMed ID: 16305058
    [No Abstract]   [Full Text] [Related]  

  • 2. What's new in type 2 diabetes?
    McCarthy JC; Pearson RD
    J Fam Pract; 2012 Nov; 61(11):646-51. PubMed ID: 23256094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 6. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract]   [Full Text] [Related]  

  • 7. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
    Crouch MA
    Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359
    [No Abstract]   [Full Text] [Related]  

  • 8. [A search for novel pathways of effective prevention of cardiovascular complications in patients with type 2 diabetes mellitus: advance trial].
    Karpov IuA; Shubina AT
    Kardiologiia; 2007; 47(10):90-5. PubMed ID: 18260953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diabetologist/cardiologist debate: a meeting of the minds.
    Mohamed F; Aalbers J
    Cardiovasc J Afr; 2012 Mar; 23(2):115-7. PubMed ID: 22447480
    [No Abstract]   [Full Text] [Related]  

  • 11. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes.
    Cardiovasc J Afr; 2007; 18(5):343-4. PubMed ID: 17985038
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome results renew debate about diabetes drug development.
    Mullard A
    Lancet Diabetes Endocrinol; 2013 Nov; 1(3):179-80. PubMed ID: 24622363
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.
    Saxon DR; Rasouli N; Eckel RH
    Drugs; 2018 Feb; 78(2):203-214. PubMed ID: 29305768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the cardiovascular safety of diabetes therapies.
    Goldfine AB
    N Engl J Med; 2008 Sep; 359(11):1092-5. PubMed ID: 18784098
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure control in type 2 diabetes.
    de Galan BE
    N Engl J Med; 2010 Aug; 363(7):695-6; author reply 697. PubMed ID: 20842774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Revised blood pressure goals and no elevated glucose readings in between].
    MMW Fortschr Med; 2005 Dec; 147(51-52):72. PubMed ID: 16402718
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fixed drug combinations--the pros and the cons].
    Rustenbeck I
    Med Monatsschr Pharm; 2009 Apr; 32(4):141-6. PubMed ID: 19445271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive glucose control in type 2 diabetes.
    Parashar A
    N Engl J Med; 2008 Oct; 359(14):1520; author reply 1520-1. PubMed ID: 18837128
    [No Abstract]   [Full Text] [Related]  

  • 19. Getting to the heart of the matter in type 2 diabetes.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):827. PubMed ID: 26476884
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus.
    Weidman-Evans E; Metz SM; Evans JD
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):225-33. PubMed ID: 24490745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.